Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 320542, 6 pages
http://dx.doi.org/10.1155/2012/320542
Research Article

The Observation of Humoral Responses after Influenza Vaccination in Patients with Rheumatoid Arthritis Treated with Japanese Oriental (Kampo) Medicine: An Observational Study

1Department of Japanese Oriental Medicine, Gunma Central and General Hospital, Maebashi Gunma 371-0025, Japan
2Department of Internal Medicine, Gunma Central and General Hospital, Maebashi Gunma 371-0025, Japan
3Department of Japanese Oriental Medicine, Kobe Century Memorial Hospital, Japan

Received 2 December 2011; Accepted 1 February 2012

Academic Editor: Vincenzo De Feo

Copyright © 2012 Toshiaki Kogure et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Verwilghen, S. Vertessen, E. A. Stevens, J. Dequeker, and J. L. Ceuppens, “Depressed T-cell reactivity to recall antigens in rheumatoid arthritis,” Journal of Clinical Immunology, vol. 10, no. 2, pp. 90–98, 1990. View at Google Scholar · View at Scopus
  2. J. C. Beckham, D. S. Caldwell, B. L. Peterson et al., “Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures,” Journal of Clinical Immunology, vol. 12, no. 5, pp. 353–361, 1992. View at Google Scholar · View at Scopus
  3. T. Kogure, T. Itoh, Y. Shimada, T. Shintani, H. Ochiai, and K. Terasawa, “Detection of serum soluble markers of immune activation in rheumatoid arthritis,” Mediators of Inflammation, vol. 5, no. 4, pp. 262–265, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Koetz, E. Bryl, K. Spickschen, W. M. O'Fallon, J. J. Goronzy, and C. M. Weyand, “T cell homeostasis in patients with rheumatoid arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 9203–9208, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. T. M. Govaert, C. T. Thijs, N. Masurel, M. J. Sprenger, G. J. Dinant, and J. A. Knottnerus, “The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial,” Journal of the American Medical Association, vol. 272, no. 21, pp. 1661–1665, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. Ehrenstein, J. G. Evans, A. Singh et al., “Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFa therapy,” Journal of Experimental Medicine, vol. 200, no. 3, pp. 277–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Wolfe, D. M. Mitchell, J. T. Sibley et al., “The mortality of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 37, no. 4, pp. 481–494, 1994. View at Google Scholar · View at Scopus
  8. Centers for Disease Control and Prevention, “Prevention of pneumococcal disease: recommendations of the advisory committee on immunization practices (ACIP),” Morbidity and Mortality Weekly Report, vol. 55, pp. 1–42, 2006. View at Google Scholar
  9. I. Fomin, D. Caspi, V. Levy et al., “Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFa blockers,” Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 191–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Chalmers, D. Scheifele, C. Patterson et al., “Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity,” Journal of Rheumatology, vol. 21, no. 7, pp. 1203–1206, 1994. View at Google Scholar · View at Scopus
  11. D. M. Chang, W. Y. Chang, S. Y. Kuo, and M. L. Chang, “The effects of traditional antirheumatic herbal medicines on immune response cells,” Journal of Rheumatology, vol. 24, no. 3, pp. 436–441, 1997. View at Google Scholar · View at Scopus
  12. K. Asano, J. Matsuishi, Y. Yu, T. Kasahara, and T. Hisamitsu, “Suppressive effects of Tripterygium wilfordii Hook f., a traditional Chinese medicine, on collagen arthritis in mice,” Immunopharmacology, vol. 39, no. 2, pp. 117–126, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Kobayashi, H. Kobayashi, H. Matsuno, I. Kimura, and M. Kimura, “Inhibitory effects of anti-rheumatic drugs containing magnosalin, a compound from “Shin-I” (Flos magnoliae), on the proliferation of synovial cells in rheumatoid arthritis models,” Immunopharmacology, vol. 39, no. 2, pp. 139–147, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Niizawa, T. Kogure, L. X. Hai et al., “Clinical and immunomodulatory effects of Fun-boi, an herbal medicine, on collagen-induced arthritis in vivo,” Clinical and Experimental Rheumatology, vol. 21, no. 1, pp. 57–62, 2003. View at Google Scholar · View at Scopus
  15. L. X. Hai, T. Kogure, A. Niizawa et al., “Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice,” Journal of Rheumatology, vol. 29, no. 8, pp. 1601–1608, 2002. View at Google Scholar · View at Scopus
  16. T. Kogure, T. Tatsumi, A. Niizawa, H. Fujinaga, Y. Shimada, and K. Terasawa, “The population of CD40L-expressing cells was slightly but not significant decreased in lymphoid tissues of collagen induced arthritic mice treated with Hochu-Ekki-To,” Yakugaku Zasshi, vol. 127, no. 3, pp. 547–550, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. L. Prevoo, M. A. van't Hof, H. H. Kuper, M. A. van Leeuwen, L. B. van de Putte, and P. L. van Riel, “Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 44–48, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Holvast, A. Huckriede, J. Wilschut et al., “Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease,” Annals of the Rheumatic Diseases, vol. 65, no. 7, pp. 913–918, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. C. de Jong, A. M. Palache, W. E. Beyer, G. F. Rimmelzwaan, A. C. Boon, and A. D. Osterhaus, “Haemagglutination-inhibiting antibody to influenza virus,” Developments in Biologicals, vol. 115, pp. 63–73, 2003. View at Google Scholar · View at Scopus
  20. I. Fomin, D. Caspi, V. Levy et al., “Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFa blockers,” Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 191–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. van Assen, A. Holvast, C. A. Benne et al., “Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab,” Arthritis and Rheumatism, vol. 62, no. 1, pp. 75–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Nogami, N. Sekiya, T. Mitsuma, and T. Yamaguchi, “A case of pulmonary Mycobacterium fortuitum infection successfully treated with Kampo treatments,” Kekkaku, vol. 81, no. 8, pp. 525–529, 2006. View at Google Scholar · View at Scopus
  23. N. Mantani, Y. Kasahara, T. Kamata et al., “Effect of Seihai-to, a Kampo medicine, in relapsing aspiration pneumonia—an open-label pilot study,” Phytomedicine, vol. 9, no. 3, pp. 195–201, 2002. View at Google Scholar · View at Scopus
  24. A. Nakajima, E. Inoue, E. Tanaka et al., “Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA,” Scandinavian Journal of Rheumatology, vol. 39, no. 5, pp. 360–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Bijl, N. Agmon-Levin, J. M. Dayer, E. Israeli, M. Gatto, and Y. Shoenfeld, “Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment,” Autoimmunity Reviews, In press.
  26. F. Conti, S. Rezai, and G. Valesini, “Vaccination and autoimmune rheumatic diseases,” Autoimmunity Reviews, vol. 8, no. 2, pp. 124–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Stojanovich, “Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA),” Clinical and Developmental Immunology, vol. 13, no. 2–4, pp. 373–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Sibilia and J. F. Maillefert, “Vaccination and rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 61, no. 7, pp. 575–576, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Oren, M. Mandelboim, Y. Braun-Moscovici et al., “Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 937–941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Toplak, T. Kveder, A. Trampus-Bakija, V. Subelj, S. Cucnik, and T. Avcin, “Autoimmune response following annual influenza vaccination in 92 apparently healthy adults,” Autoimmunity Reviews, vol. 8, no. 2, pp. 134–138, 2008. View at Google Scholar
  31. T. Kogure, H. Sato, D. Kishi, T. Ito, and T. Tatsumi, “Serum levels of anti-cyclic citrullinated peptide antibodies are associated with a beneficial response to traditional herbal medicine (Kampo) in rheumatoid arthritis,” Rheumatology International, vol. 29, no. 12, pp. 1441–1447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. C. A. Murphy, C. L. Langrish, Y. Chen et al., “Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1951–1957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura, “Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice,” Journal of Immunology, vol. 171, no. 11, pp. 6173–6177, 2003. View at Google Scholar · View at Scopus
  34. H. Kawamata, H. Ochiai, N. Manlani, and K. Terasawa, “Enhanced expression of inducible nitric oxide synthase by Juzen-Taiho-To in LPS-activated RAW264.7 Cells, a murine macrophage cell line,” American Journal of Chinese Medicine, vol. 28, no. 2, pp. 217–226, 2000. View at Google Scholar · View at Scopus
  35. T. Kogure, A. Niizawa, L. X. Hai et al., “Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 60, no. 2, pp. 166–169, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Hayashi, N. Imanishi, Y. Kashiwayama et al., “Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo,” Antiviral Research, vol. 74, no. 1, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Mantani, N. Imanishi, H. Kawamata, K. Terasawa, and H. Ochiai, “Inhibitory effect of (+)-catechin on the growth of influenza A/PR/8 virus in MDCK cells,” Planta Medica, vol. 67, no. 3, pp. 240–243, 2001. View at Publisher · View at Google Scholar · View at Scopus